News

Mauna Kea Technologies reports full financial results for first half of 2020 and preliminary third quarter of 2020 sales

22 September 2020

1H’20 financial results driven primarily by a 10% reduction in total operating expenses (without COGS) and a 17% reduction in net loss compared to prior year period 
Preliminary Third Quarter Total Sales Increase 2% to 11% year-over-year; U.S. Sales up 1% to 3% 

Mauna Kea Technologies today announced full financial results for the first half of 2020 ended June 30, 2020 and its preliminary sales for the third quarter. Given the significant uncertainties associated with pace of recovery from the COVID-19 pandemic, the Company has elected to provide, in this context, specific information on current-quarter expected revenue trends.

Latest News

Mauna Kea Technologies Announces Two New Peer-Reviewed Clinical Studies Confirming the Clinical Value of Cellvizio® and Its Combination with AI for the Diagnosis of Pancreatic Cysts 

Mauna Kea Technologies Announces Two New Peer-Reviewed Clinical Studies Confirming the Clinical Value of Cellvizio® and Its Combination with AI for the Diagnosis of Pancreatic Cysts 

Mauna Kea Technologies Reports Strong H1 2026 Core Sales Growth 

Mauna Kea Technologies Reports Strong H1 2026 Core Sales Growth 

Mauna Kea Technologies to Host a Webinar on July 21, 2026 To Discuss Its First-Half Business Activity

Mauna Kea Technologies to Host a Webinar on July 21, 2026 To Discuss Its First-Half Business Activity

No results found.